1. Home
  2. SYBT vs BHVN Comparison

SYBT vs BHVN Comparison

Compare SYBT & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stock Yards Bancorp Inc.

SYBT

Stock Yards Bancorp Inc.

N/A

Current Price

$78.37

Market Cap

2.6B

Sector

Finance

ML Signal

N/A

Logo Biohaven Ltd.

BHVN

Biohaven Ltd.

N/A

Current Price

$15.74

Market Cap

2.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SYBT
BHVN
Founded
1904
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.3B
IPO Year
2009
2022

Fundamental Metrics

Financial Performance
Metric
SYBT
BHVN
Price
$78.37
$15.74
Analyst Decision
Hold
Buy
Analyst Count
4
14
Target Price
$76.00
$29.08
AVG Volume (30 Days)
113.1K
2.9M
Earning Date
04-22-2026
05-11-2026
Dividend Yield
1.81%
N/A
EPS Growth
22.11
26.08
EPS
2.55
N/A
Revenue
$23,406,000.00
N/A
Revenue This Year
$17.31
N/A
Revenue Next Year
$9.32
N/A
P/E Ratio
$31.06
N/A
Revenue Growth
3.37
N/A
52 Week Low
$61.51
$7.48
52 Week High
$89.22
$18.57

Technical Indicators

Market Signals
Indicator
SYBT
BHVN
Relative Strength Index (RSI) 32.94 57.49
Support Level $77.35 $8.84
Resistance Level $78.73 $17.01
Average True Range (ATR) 1.79 1.20
MACD -0.74 0.18
Stochastic Oscillator 7.91 55.53

Price Performance

Historical Comparison
SYBT
BHVN

About SYBT Stock Yards Bancorp Inc.

Stock Yards Bancorp Inc operates as a bank holding company providing commercial banking and wealth management services. Its Commercial Banking segment offers loan and deposit products to consumers and businesses, including retail and mortgage lending, deposit services, online and mobile banking, private banking, commercial and real estate lending, treasury and merchant services, international and correspondent banking, credit cards, and brokerage services through a third-party broker-dealer. Its Wealth Management and Trust (WM&T) segment provides investment management, financial and retirement planning, trust and estate services, and retirement plan management, with WM&T revenue distinguishing the company from similarly sized community banks.

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.

Share on Social Networks: